Julie Gralow Selected Research

Julie Gralow Research Topics

Disease

39	Breast Neoplasms (Breast Cancer) 10/2022 - 08/2002
28	Neoplasms (Cancer) 02/2024 - 08/2002
8	Neoplasm Metastasis (Metastasis) 04/2022 - 11/2003
6	Pain (Aches) 07/2016 - 11/2003
3	Triple Negative Breast Neoplasms 04/2022 - 01/2010
3	Osteonecrosis (Kienbock's Disease) 02/2021 - 02/2005
3	Infections 11/2013 - 01/2006
2	Febrile Neutropenia 04/2022 - 12/2007
2	Disease Progression 04/2022 - 01/2019
2	Neutropenia 04/2022 - 06/2008
2	Arthralgia (Joint Pain) 12/2018 - 10/2015
2	Osteoporosis 07/2016 - 01/2005
2	Hypertension (High Blood Pressure) 10/2008 - 12/2007
2	Lung Neoplasms (Lung Cancer) 01/2008 - 01/2007
2	Head and Neck Neoplasms (Head and Neck Cancer) 01/2008 - 01/2007
2	Kidney Neoplasms (Kidney Cancer) 01/2008 - 01/2007
1	Premature Menopause 10/2023
1	Meningeal Carcinomatosis 10/2019
1	Fatigue 01/2019
1	autosomal recessive 1 Spinocerebellar ataxia 12/2018
1	Pathologic Complete Response 01/2018
1	Residual Neoplasm 01/2018
1	Bone Fractures (Bone Fracture) 07/2016
1	Musculoskeletal Pain 10/2015
1	Osteoarthritis 10/2015
1	Diarrhea 12/2012
1	Leukemia 05/2010
1	Spontaneous Fractures (Pathological Fracture) 03/2010
1	Hypercalcemia (Milk Alkali Syndrome) 03/2010
1	Bone Resorption 03/2010
1	Spinal Cord Compression 03/2010

Drug/Important Bio-Agent (IBA)

14	Hormones (Hormone)IBA 10/2022 - 08/2002
7	ErbB Receptors (EGF Receptor)IBA 10/2022 - 01/2010
7	Aromatase InhibitorsIBA 12/2018 - 08/2002
6	Trastuzumab (Herceptin)FDA Link 10/2022 - 08/2013
6	human ERBB2 proteinIBA 10/2022 - 08/2013
6	Capecitabine (Xeloda)FDA Link 04/2016 - 06/2008
5	taxaneIBA 10/2022 - 02/2008
5	Diphosphonates (Bisphosphonates)IBA 03/2010 - 11/2003
4	Estrogen ReceptorsIBA 01/2021 - 01/2010
4	Bevacizumab (Avastin)FDA Link 01/2019 - 12/2007
4	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2018 - 11/2014
4	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2018 - 11/2014
3	Progesterone Receptors (Progesterone Receptor)IBA 01/2021 - 01/2010
3	130-nm albumin-bound paclitaxelIBA 01/2019 - 01/2018
3	Tamoxifen FDA LinkGeneric 07/2016 - 08/2002
3	Proteins (Proteins, Gene)FDA Link 10/2015 - 10/2013
3	Paclitaxel (Taxol)FDA LinkGeneric 11/2014 - 12/2007
2	Taxoids (Taxanes)IBA 10/2022 - 04/2010
2	AnthracyclinesIBA 10/2022 - 06/2008
2	Zoledronic Acid (Zometa)FDA Link 02/2021 - 02/2005
2	Methotrexate (Mexate)FDA LinkGeneric 10/2019 - 03/2016
2	Omega-3 Fatty Acids (Omega 3 Fatty Acids)IBA 12/2018 - 10/2015
2	Letrozole (Femara)FDA LinkGeneric 01/2018 - 07/2016
2	Biomarkers (Surrogate Marker)IBA 01/2018 - 10/2008
2	Anastrozole (Arimidex)FDA LinkGeneric 01/2016 - 08/2002
2	Monoclonal AntibodiesIBA 03/2010 - 12/2007
2	DNA (Deoxyribonucleic Acid)IBA 01/2010 - 10/2008
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 10/2008 - 12/2007
1	Antineoplastic Agents (Antineoplastics)IBA 10/2023
1	Ado-Trastuzumab EmtansineIBA 10/2022
1	pertuzumabIBA 10/2022
1	Uridine Diphosphate (UDP)IBA 04/2022
1	Glucuronosyltransferase (UDP Glucuronosyltransferase)IBA 04/2022
1	sacituzumab govitecanIBA 04/2022
1	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 04/2022
1	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 01/2021
1	Cytarabine (Cytosar-U)FDA LinkGeneric 10/2019
1	Erlotinib Hydrochloride (CP 358,774)FDA Link 01/2019
1	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 12/2018
1	thiamine triphosphorate (TTP)IBA 12/2018
1	Immune Checkpoint InhibitorsIBA 01/2018
1	Metformin (Glucophage)FDA LinkGeneric 05/2017
1	Lapatinib (GW572016)FDA Link 05/2017
1	Insulin (Novolin)FDA Link 05/2017
1	Fluorouracil (Carac)FDA LinkGeneric 03/2016
1	Fulvestrant (Faslodex)FDA Link 01/2016
1	Corn Oil (Oil, Corn)IBA 10/2015
1	Triglycerides (Triacylglycerol)IBA 10/2015
1	Goserelin (Zoladex)FDA Link 01/2015
1	Gonadotropin-Releasing Hormone (GnRH)FDA Link 01/2015
1	B 31IBA 11/2014
1	Epidermal Growth Factor (EGF)IBA 10/2014
1	Recombinant ProteinsIBA 11/2013
1	Desmoglein 2IBA 11/2013
1	Indicators and Reagents (Reagents)IBA 08/2013
1	Pemetrexed (MTA)FDA Link 04/2010
1	Gemcitabine FDA Link 04/2010
1	collagen type I trimeric cross-linked peptideIBA 03/2010
1	Denosumab FDA Link 03/2010
1	PlatinumIBA 01/2010

Therapy/Procedure

25	Therapeutics 02/2024 - 08/2002
14	Drug Therapy (Chemotherapy) 04/2022 - 01/2006
7	Adjuvant Chemotherapy 01/2019 - 05/2010
3	Radiotherapy 03/2010 - 01/2006
1	Dental Care 02/2021
1	Neoadjuvant Therapy 01/2018
1	Palliative Care (Palliative Therapy) 01/2017
1	Duration of Therapy 07/2016
1	Combination Drug Therapy (Combination Chemotherapy) 11/2014